New Drug Approvals
Vasovist (gadofosveset trisodium) - formerly MS-325 Date of Approval: December 22, 2008 Company: EPIX Pharmaceuticals, Inc. Treatment for: Diagnostic Vasovist (gadofosveset trisodium) is a blood pool magnetic resonance angiography (MRA) agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease. ZolpiMist (zolpidem tartrate) Oral Spray Date of Approval: December 22, 2008 Company: NovaDel Pharma, Inc. Treatment for: Insomnia ZolpiMist is an oral spray formulation of zolpidem, the drug contained in Ambien. ZolpiMist is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Oral Fludarabine (fludarabine phosphate) Tablets Date of Approval: December 19, 2008 Company: Antisoma plc Treatment for: Chronic Lymphocytic Leukemia Oral fludarabine (fludarabine phosphate) is an oral nucleoside analogue approved as a single agent for the treatment of adult patients with B-cell chronic lymp...